SCYX
SCYNEXIS, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$5.30
−0.84%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.13x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.19x
- Net debt / EBITDA
- 0.83x
Liquidity & coverage
- Current ratio
- 9.65x
- Quick ratio
- 9.65x
- Cash ratio
- 9.28x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $50.4M
Cash & dividend
- FCF / debt
- -6.84x
- Cash flow / debt
- -6.84x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026